Disparities in cardiovascular disease mortality after breast cancer treatment: methodological considerations using real-world data Published December 2021 Citation Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K. . Cancer. . https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34045 Authors:Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K Sources:Cancer Share Posted inPublicationsHealth equityBreast cancer More publicationsSABCSDecember 2025Racial/ethnic inequities in access to novel therapies and outcomes in triple negative breast cancerMbah O, Ho G, Keane C, Dolor A, Ryals C.Publication summaryPublicationsHealth equityBreast cancerAACR Special Conference in Cancer Research: Artificial Intelligence and Machine LearningJuly 2025Fairness by design: End-to-end bias evaluation for LLM-generated dataEstevez M, Mbah O, Sheikh A, et al.Publication summaryPublicationsData scienceHealth equityBreast cancerArtificial intelligenceBlood and Lymphatic Cancer: Targets and TherapyMarch 2026Health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2Espinoza-Gutarra M, Jarrett B, Wang X, Afghahi A, Bae S. Publication summaryPublicationsHealth equityTreatment patternsAcute myeloid leukemia